FIELD: medicine, pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to a method for producing pharmaceutical tablets containing low doses of tamzulosin. These tablets are used in treatment of prostate benign hyperplasia. Tablets can be produced without addition of liquid that provides simplifying the tabletting process. Method provides decreasing cost of the technological process in producing tablets.
EFFECT: improved producing method.
29 cl, 7 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS OF ACTIVE PHARMACEUTICAL INGREDIENT STABILISATION | 2005 |
|
RU2391115C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING 5,8,14-TRIAZATETRACYCLO[10,3,1,0(2,11),0(4,9)HEXADECA-2( 11),3,5,7,9-PENTAENE | 2002 |
|
RU2272629C2 |
| TABLETS OF TAMSULOSIN WITH MODIFIED RELEASE | 2002 |
|
RU2335280C2 |
| MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
| LAMOTRIGINE-BASED COMPOSITIONS OF PROLONGED RELEASE | 2003 |
|
RU2325163C2 |
| COMPOSITIONS AND METHODS FOR TREATING CANCER | 2017 |
|
RU2770081C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DGAT1 INHIBITOR | 2011 |
|
RU2595866C2 |
| DRUG COMPOSITIONS CONTAINING CONTROLLED RELEASE HYPROMELLOSE MATRIXES | 2006 |
|
RU2414241C2 |
| COMPOSITION AND METHOD OF DIRECT COMPRESSING | 2005 |
|
RU2391097C2 |
| HALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2005 |
|
RU2384328C2 |
